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Adverse Cardiovascular Effects  
and Drug Interactions with Herbs
Ioannis Chaveles, MD, Nikolaos Sakellaris, MD, Ioannis Pyrros, MD
A b s t r A c t
Herbs are plants or products of plants used since antiquity and despite their wide-
spread promotion, their purity, efficacy and safety are often unknown. The healthcare 
professionals may be asked to give advice on the use of these products, in conjunction 
with other medications. Thus, they can potentially interact with the cardiovascular 
drugs with subsequent dramatic effects on the coagulation pathways and the platelets 
adhesion. The administration of herbs in patients suffering from cardiovascular dis-
eases should be done sparingly, with caution, and with thorough knowledge of their 
possible interactions with the already prescribed drugs.
I n t r o d u c t I o n
Herbal supplements have been used since ancient times, especially in the East. 
The ancient Greeks used herbs as a key tool in their therapeutic armamentarium. A 
recent resurgence in their popularity has been noted in the West. Multiple factors 
contribute to this growing use of complementary and alternative medicine (CAM), 
including the general desire of good health and wellness and the traditional belief 
that CAM is safer and more effective than the commonly used prescribed drugs which 
usually have side effects. 
Herbs are plants or products of plants with widespread use. Because herbs, which 
constitute the largest proportion of CAM use in the United States, are regarded as 
food products, they are not subjected to the same scrutiny and regulations as tradi-
tional medications.
The use of herbal products is prevalent particularly among senior citizens, who 
are taking prescription medications and usually do not really disclose the use of 
CAM to their health care providers. Many of these products may have potentially 
harmful effects on the cardiovascular system, interacting with the commonly used 
well-established conventional medical therapy at a clinically significant degree. 
A few clinical studies have systematically assessed potential interactions between 
herbs and medications. However, potentially serious consequences might be 
avoided by obtaining a more careful history about CAM use. 
In the present review, we will briefly summarize the basis of the pathogenetic 
mechanisms of adverse reactions on the cardiovascular system with the herbs. 
Also, we provide a report of their interactions with the commonly used drugs, 
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in patients with heart diseases. Finally, we suggest ways to 
improve their safety, so as to achieve better protection of the 
public from untoward effects.
H e r b s  A n d  v I t A m I n s 
Herbal remedies and high doses of vitamins are used by 
over 15 million U.S. citizens.1 The majority of the consumers 
are elderly, in whom the incidence of cardiovascular disease 
and thus the use of cardiac medications, is high. This wide-
spread use is increasing dramatically and yet current laws allow 
these herbal remedies to be marketed as dietary supplements, 
and thus they are not subjected to the same regulations which 
are required for drug prescriptions.2 The most commonly used 
herbs and their interactions with the cardiovascular drugs are 
enlisted in Table 1.3 These interactions are especially relevant, 
when cardiovascular medications with a narrow therapeutic 
index, such as digoxin and warfarin, are co-administrated with 
some of the herbs.4 These seemingly innocent formulations, 
cost Americans 34 billion $/year and there is an increase in 
their out-of-pocket money cost of 6-7% per year, mostly on 
weight loss formulations.7 Herbs are plants or plant products, 
and they are not subject to thorough checks on safety and ef-
ficacy.8 Some of them have a direct effect on the cardiovascular 
or the coagulation system, while others have indirect effects 
due to interactions (Table 2).5,6 Below we discuss the most 
frequently used herbs which could be taken either alone or in 
combination, as nutritional supplements.
balsam or sedge (st. John’s wort) is one of the 10 most 
popular herbs. St. John’s wort is the common name for 
Hypericum perforatum, a yellow flower with a long and rich 
history. It contains a vast array of chemical compounds. The 
major chemical components are naphthodianthrones, of 
which hypericin, pseudohypericin, and hyperforin are the most 
revelant biologically active compounds. St John’s wort also 
contains quercetin, flavones and xanthoids. It is used against 
depression, mania, sleep disorders, common cold, herpes, 
human immunodeficiency virus (HIV), as local anesthetic, 
or as an enema for ulcerative colitis.10 It induces the hepatic 
cytochrome P450, particularly the CYP3A4 enzyme 17 which 
is involved in the oxidative metabolism of more than half of 
prescribed medications (Table 3).9,10 This combination re-
duces the bioavailability and the efficacy of antihypertensive 
and antiarrhythmic drugs. Balsam halves the concentration 
of cyclosporine,14 ethinyl oestradiol and indinavir11 and is a 
particular problem in heart-transplanted patients.13 It reduces 
the effect of warfarin, decreases the prothrombin time and the 
concomitant subtherapeutic anticoagulant effect increases 
the risk of thromboembolism.19 It also reduces the levels of 
statins,15 induces gene product P-glycoprotein, reduces the 
active levels of digoxin,16 enhances the hypoglycemic effect of 
antidiabetic agents and the adrenergic activity of serotonin.20 
Hawthorn (motherwort) is the common name for Cratae-
gus Oxyacantha and is often known as May bush or Thorn apple 
tree. The major chemical components are proanthocyanidins, 
flavonoids and catechins (epicatechin). It is a herb with nar-
cotic and spasmolytic properties. It is used for the treatment 
of tachycardia, arrhythmia, anxiety, insomnia and amenorrhea 
and it is also a diuretic drug. If administrated intravenously it 
has antihypertensive effect and reduces platelet aggregation 
and fibrinogen levels, thereby it increases the risk of bleeding.21 
Ginseng is used in a wide variety of products, especially 
in multivitamin preparations.23 It is advertised as immune 
adjuvant, antidiabetic and stimulant of libido. It may have 
hypertensive, but also hypotensive effect, due to increased 
synthesis of nitric oxide (NO).22 It is reported to have a wide 
range of pharmacological activities, because of a diversified 
group of steroidal saponins called ginsenosides. The bioavail-
ability after taking ginseng orally is low, and the metabolites 
of ginsenosides produced by gut microbiota may be biologi-
cally active.
In Chinese medicine it is used for myocardial infarction, 
congestive heart failure (CHF) and unstable angina, but 
recent data contradict this issue. Ginseng’s overuse causes 
hypertension, abnormal behavior and diarrhea. It contains the 
nephrotoxic component of germanium that can destroy cells 
in the ascending limb of the loop of Henle with consequent 
diuretic resistance.24 Finally, it reduces the effect of warfarin 
and increases the levels of digitalis.25
Ginkgo bilova is one of the longest living tree species in 
the world, and is used for cardiovascular, cerebrovascular 
and peripheral vascular disease, impotence, disorders of the 
inner ear, retinopathy, stress, depression and dementia.26 It 
increases the risk of bleeding and the anticoagulant activity 
after interacting with cytochrome P450.27 Finally, it decreases 
the activity of nicardipine.
Garlic, since the papyrus of Ebers (1550 B.C), is used as 
antimicrobial, anti-inflammatory, antihypertensive and anti-
atherosclerotic agent.28 A recent study showed no significant 
statistical difference of garlic in lowering low-density lipopro-
tein (LDL) and other plasma lipids, over a period of 6 months, 
compared with placebo.29 In experiments in rats, dietary garlic 
inhibited the synthesis of lipids in the liver and increased the 
level of serum insulin. Also, it can increase the risk of bleed-
ing in patients receiving anticoagulants because of the active 
ingredient “ajoene” that inhibits the collagen-induced platelet 
aggregation. Garlic preparations should be discontinued 10 
days prior to selective surgery especially in patients receiving 
aspirin or warfarin.30,31
Grapefruit’s juice is used as a diet formula and for the 
“improvement of the cardiovascular system”. It is a source of 
vitamin C, fiber, potassium, pectin and other nutrients. The 
components of “naringenin” and “bergamottin” inhibit the 
enzyme CYP3A4 which is located in the cells of the small in-
testine, leading to rising levels of medications, such as calcium 
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tAble 1. Common Herb–Drug Interactions
Herb drug or drug class Interaction / comments
Danshen Anticoagulant or antiplatelet agents Increases bleeding due to additive effects
Digoxin Increases side effects of digoxin
Echinacea Amiodarone or ibutilide Increases QT interval
Statins, fibrates, niacin Increases risk of hepatotoxic effects
Ephedra Antidiabetes drugs Increases blood glucose
Decreases effectiveness of oral hypoglycemic agents
Class IA and class III antiarrhythmics Increases QT interval
Beta-blockers Decreases effects of beta-blockers, leading to hypertension and 
tachycardia
Monoamine oxidase inhibitors Hypertension
Garlic Aspirin, clopidogrel, warfarin, or heparinoid drugs Increases bleeding risk
Biloba Antidiabetes drugs Increases hypoglycemia
Aspirin Increases bleeding
Ginseng Warfarin Inhibits PAF hemorrhage
Antidiabetes drugs Increases hypoglycemia
Digoxin Interferes with digoxin assay, leading to falsely increased levels
Warfarin Decreases effectiveness of warfarin
Hawthorn Phenelzine sulfate Headache / Irritability / Insomnia
Digoxin Increases effects of digoxin
Licorice Calcium-channel blockers or nitrates Increases vasodilatory effects
Saw palmetto Spironolactone Increases effects of spironolactone
Soy milk Anticoagulant or antiplatelet agents Increases bleeding
St. John’s wort Warfarin Decreases effectiveness of warfarin
Digoxin Decreases serum digoxin concentration
Clopidogrel Increases activity of clopidogrel Increases bleeding
Warfarin Decreases warfarin bioavailability and effectiveness
Simvastatin Decreases effectiveness of simvastatin
Paroxetine Nausea / Lethargy / Incoherence
Class IA and III antiarrhythmic agents Decreases effectiveness (precipitating arrhythmias)
Cyclosporine Decreases cyclosporine concentration due to increased clearance 
(transplant rejection)
Theophylline Decreases serum concentration
Indinavir Decreases serum concentration (treatment failure in HIV patients)
ACE = angiotensin-converting enzyme; CNS = central nervous system; HIV = human immunodeficiency virus; PAF = platelet-activating factor. 
channel blockers,32 cyclosporine, statins, midazolam, estrogen, 
terazosin, and thus it can result in hypotension, myopathy and 
hepatotoxicity respectively.33
Hawthorn (buckthorn) is used for angina, bradyarrhyth-
mia and brain impairment. It has positive inotropic and vaso-
dilatory properties and it is thought to increase myocardial 
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perfusion and to decrease the left ventricular afterload.34,35 
Actually, it improves symptoms but does not reduce morbid-
ity and mortality. It increases the levels of digitalis and the 
biosynthesis of thromboxane A2 and it may increase the risk 
of bleeding in patients receiving anticoagulants.
saw palmetto (berry) is used by more than 2 million men 
in U.S.A for the treatment of benign prostatic hypertrophy,37 
as a diuretic, and as a urinary tract antiseptic. In vitro it inhibits 
the alpha1-adrenergic receptors38 and cyclooxygenase activity, 
and increases the associated with warfarin bleeding.39
tetrandrine is a vasoactive alkaloid which is used in 
Chinese medicine to treat angina and hypertension. The 
inhibition of the L-type calcium channels causes vasodila-
tion and may interact with other calcium antagonists.41 It has 
anti-inflammatory, immunologic and antiallergic effects. It 
inhibits the degranulation of mast cells. It has “quinidine-like” 
antiarrhythmic effect.
Aconite (wolf’s bane) is a strong analgesic,42 which has 
bradycardic effects due to action in brain receptors. Atrial or 
ventricular fibrillation can be caused by direct action on the 
myocardium. Even an accidental contact with the leaves or the 
juice of the plant, can cause poisoning due to bradycardia or 
fatal ventricular arrhythmia which is induced by triggered activ-
ity, and hence its appellation of the “Queen of all poisons”.43, 44 
Gynura or Gynura procumbens is cultivated in South-
eastern Asia and is used to improve microcirculation and to 
eliminate pain. It often has adverse effects, like hepatotoxicity 
in animals,45 and inhibits angiotensin converting enzyme lead-
ing to hypotension.46
danshen (salvia miltiorrhiza) or red sage is used for 
congestive heart failure (CHF) and menstrual abnormalities. 
It increases the risk of bleeding significantly, due to inhibition 
of c-AMP and increases prothrombin time. It can also increase 
the levels of digitalis.47
echinacea is widely used to fight infections, especially the 
common cold and upper respiratory infections. It can increase 
the hepatotoxicity of statins, fibrates, niacin and amiodarone. 
Echinacea flavonoids may as well inhibit and induce cyto-
chrome P450.48
tAble 2. Commonly Used Herbs that can Potentiate the 
Risk of Bleeding and Arrhythmogenesis
bleeding Arrhythmogenesis
Bilberry Aloe vera
Danshen Bitter orange
Garlic Echinaceae
Ginko bilova Ginko bilova
Gingeng Gingeng
Motherwort Hawthorn
Sawpalmetto Licorice
Alfalfa St John’s wort
Dong qual Guarana
tAble 3. Common Cardiovascular Drugs Metabolized by 
the CYPEA4 System
medication category drug name
Antiarrhythmic agents Amiodarone, disopyramide, 
flecainide,* lidocaine, mexiletine, 
quinidine**
Angiotensin receptor 
antagonist
Irbesartan
b-blockers Metoprolol,* carvedilol
Calcium-channel blocker Amlodipine besylate, felodipine, 
nifedipine, diltiazem, verapamil
HMG-CoA reductase 
inhibitor (statins)
Atorvastatin, cerivastatin, 
fluvastatin, lovastatin,
*also by CYP2D6, **also by CYP2D1
HMG-CoA = 3-hydroxy-3-methylglutaryl-coenzyme A
tAble 4. Herbal Products to be Avoided in Cardiovascular Diseases
Herb Purpoted use Adverse effects
Αlfalfa Arthritis, asthma, diabetes, hyperlipidemia Increases bleeding risk with warfarin
Aloe Vera Wounds, diabetes Hypokalemia and digitalis toxicity, arrhythmia
Angelica (dong quai) Dyspepsia, infection, appetite loss Increases bleeding risk with warfarin
Bilberry Arthritis, circulatory disorders, local inflammation Increases bleeding risk with warfarin
Butcher’s broom circulatory disorders, inflammation, leg cramps Decreases effects of alpha-blockers
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licorice (liquorice) is widely used as an expectorant in 
newer cough syrups. It can cause pseudohyperaldosteronism 
with concomitant hypokalemia, hypertension and edema 
with subsequent tolerance to antihypertension medications. 
Licorice- induced hypokalemia can lead to increased risk for 
ventricular arrhythmia, particularly torsades de pointes.49 It 
can also potentiate the effects of spironolactone and digoxin, 
while its ability to inhibit thrombin and platelet aggregation 
enhances the risk of bleeding when antiplatelet and antico-
agulant agents are co-administered with it.50 
black cohosh is used in remedies against gynecological 
pathology. It may inhibit estrogen and serotonins.51 After 
estrogen replacement therapy, it has been shown to increase 
the risk of thromboembolic and cardiovascular events.52 
yohmbine is marketed for treatment of sexual disorders 
and against exhaustion. Many of these effects are attributed 
to its alpha2- adrenergic receptor antagonist activity.53 Thus, 
it increases the release of norepinephrine, resulting in inad-
equate blood pressure control in patients using antihyperten-
sive and diuretic agents. Its use is contraindicated in patients 
with hypotension or angina.54
d I s c u s s I o n
More than 30000 herbal remedies and dietary supplements 
are sold and 1000 new supplements are induced annually in 
the U.S.58 Nevertheless and despite the above mentioned evi-
dence, herbs can possibly find their place in modern medical 
treatment.55 From a methodological point of view however, 
certain disadvantages and problems are associated with their 
use. Most importantly, scientific data on safety and effective-
ness are absent and there is no standardized control and 
regulatory mechanism of their use. Their metabolism is often 
unknown. Randomized controlled studies are the best way to 
determine their efficacy and safety which are not often avail-
able, not demanded by consumers and health providers, and 
not required by regulatory agencies. The belief of the safety 
of CAM products is unsubstantiated. Even when the data are 
available, the findings are often questionable, because of lack 
of consistency in research methods, lack of standardization of 
the investigated supplements, absence of placebo groups and 
the inclusion of healthy- low risk volunteers.
Another major issue is the lack of regulatory oversight. 
The only requirement for approval is a copy of the product 
label to be sent by the manufacturer to the U.S. Food and 
Drug Administration (FDA).
The lack of quality control is another problem. There is 
a wide variation in manufacturing techniques and storage 
methods, which require urgent attention of FDA and other 
regulatory agencies. Also untested and unregulated steroids 
are sold to the public including minors. More of 40% of the 
herbs fail to contain as much of their active ingredients as 
claimed on the labels. FDA guidelines for manufacturers 
advise that they should avoid contaminating products with 
other herbs, pesticides, heavy metals and prescription drugs.56 
Nonetheless, products have been reported to contain adulter-
ant compounds and to put consumers at risk of side effects 
and drug interactions. 
The unethical marketing techniques have led to mislead-
ing advertisements and public misinformation. For instance, 
some promoted in media herbs are claimed to be “doctor 
recommended” or “presented without a prescription” and this 
leads to an unrestricted flow of equivocal and uncontrolled 
information towards the public.
Another serious problem is the lack of established data 
about herb-drug interactions by patients and health care 
providers who have no thorough knowledge of the possible 
interactions between these substances and the well established 
conventional therapy. This is most important in elderly pa-
tients with significant comorbidities. Most (64%) of patients 
with a diagnosis of atrial fibrillation, CHF, or ischemic heart 
disease reported concomitant use of alternative therapies and 
prescription drugs.57
Finally, many adverse reactions or harmful interactions 
may either be under-recognized or under-reported by both 
patients and physicians. These interactions can occur in the 
recommended dosages of these preparations. The supplement 
manufacturers also rarely report serious adverse effects to the 
FDA despite federal requirements.58
c o n c l u s I o n
Considering the wide and growing use of herbs and supple-
ments, it is essential to introduce precise rules and guidelines 
to standardize their indications. Also a scientific background 
is required, so as to direct their use, especially in complicated 
cases of significant and co existing diseases, which warrant 
the combined prescription of multiple different and mutually 
interacting medications.
Evidence of the safety and efficacy of the herbal products 
should be obtained by clinical trials, pre-marketing approval 
and strict post-marketing surveillance. Herb-drug interac-
tions are more serious when cardiovascular medications with 
a narrow therapeutic index, such as digoxin and warfarin, are 
co-administrated with herbs.4,6 Further data are required for 
the possible interactions with the new oral anticoagulants. 
Thus, the health care professionals should question 
patients about the use of herbal products. This informa-
tion is important, particularly in elderly patients at a higher 
risk of adverse interactions. Physicians should have a good 
knowledge base about herbs and vitamins and have in mind 
the possible interactions and side effects. Finally, properly 
designed clinical trials should be scheduled on the safety 
and efficacy of the herbal remedies.
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